NASDAQ: SPTX
Seaport Therapeutics, Inc.CIK 0002042347 · Pharmaceutical Preparations
10-Q
Filed Jun 8, 2026
· Period ending Mar 31, 2026
Seaport Therapeutics debuts with $238.7M IPO, advancing two neuropsychiatric trials
5 material changes detected. Sign up free to read the summary.
8-K
Filed Jun 8, 2026
· Period ending Jun 8, 2026
Seaport Therapeutics reports Q1 2026 financial results
2 material changes detected. Sign up free to read the summary.
Partner
Trade SPTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 4, 2026
· Period ending May 4, 2026
Summary not yet generated.